1.71BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00847X1046
CUSIP
00847X104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
2.90
PEG Ratio
-
Book Value
25.33
Dividend Share
-
Dividend Yield
-
Earnings Share
11.54
Wall Street Target Price
51.71
EPS Estimate Current Year
-7.14
EPS Estimate Next Year
-6.30
EPS Estimate Current Quarter
-1.76
EPS Estimate Next Quarter
-1.8533
Most Recent Quarter
-
Revenue TTM
37,035,000
Gross Profit TTM
-272,996,992
EBITDA
-434,711,008
Profit Margin
1798.26%
Return On Assets TTM
-22.88%
Return On Equity TTM
60.26%
Revenue Per Share TTM
0.649
Qtly Revenue Growth YOY
6.60%
Diluted Eps TTM
11.54
Qtly Earnings Growth YOY
0.00%
Trailing PE
2.90
Forward PE
2
Price Sales TTM
52.3403
Price Book MRQ
1.3226
Enterprise Value Revenue
29
Enterprise Value EBITDA
-2
201.96
2.08%326.09
1.06%99.34
0.88%443.80
0.63%524.00
0.61%242.09
0.57%569.19
0.00%153.01
-3.04%77.06
-2.96%551.55
-1.45%